4//SEC Filing
Tokman Alexander Y 4
Accession 0001209191-22-029593
CIK 0001681682other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:14 PM ET
Size
5.1 KB
Accession
0001209191-22-029593
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-05-16$0.20/sh+100,000$19,630→ 132,857 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1911 to $0.1963, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001334483
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:14 PM ET
- Size
- 5.1 KB